My Quote Request
No products added yet
6505-01-009-1156
20 Products
NDC50962-0125-15
POTASSIUM CHLORIDE ORAL SOLUTION,USP
NSN, MFG P/N
6505010091156
NSN
6505-01-009-1156
NDC50962-0125-15
POTASSIUM CHLORIDE ORAL SOLUTION,USP
NSN, MFG P/N
6505010091156
NSN
6505-01-009-1156
MFG
U S DEPT OF VETERANS AFFAIRS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.333 MILLIEQUIVALENTS POTASSIUM CHLORIDE PER MILLILITER
FLAVOR: ANY ACCEPTABLE
PRIMARY CONTAINER CONTENT QUANTITY: 15.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: SUGAR FREE; CONTAINS ALCOHOL 5 PCT
TOTAL PRIMARY CONTAINER QUANTITY: 100
Related Searches:
004-0065-23
FLURAZEPAM HYDROCHLORIDE CAPSULES,USP
NSN, MFG P/N
6505010091159
NSN
6505-01-009-1159
004-0065-23
FLURAZEPAM HYDROCHLORIDE CAPSULES,USP
NSN, MFG P/N
6505010091159
NSN
6505-01-009-1159
MFG
HOFFMANN-LA ROCHE INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 15.000 MILLIGRAMS FLURAZEPAM HYDROCHLORIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 30.000
CAPSULE TYPE: HARD
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
DALMANE
FLURAZEPAM HYDROCHLORIDE CAPSULES,USP
NSN, MFG P/N
6505010091159
NSN
6505-01-009-1159
DALMANE
FLURAZEPAM HYDROCHLORIDE CAPSULES,USP
NSN, MFG P/N
6505010091159
NSN
6505-01-009-1159
MFG
HOFFMANN-LA ROCHE INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 15.000 MILLIGRAMS FLURAZEPAM HYDROCHLORIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 30.000
CAPSULE TYPE: HARD
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
2897
MINERAL OIL LOTION,LANOLATED
NSN, MFG P/N
6505010092897
NSN
6505-01-009-2897
MFG
ELITE MEDICAL PRODUCTS INC .
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MINERAL OIL LOTION LANOLATED 6.5 OZ BT
PRIMARY CONTAINER CONTENT QUANTITY: 6.500 OUNCES
PRIMARY CONTAINER TYPE: BOTTLE WITH FLIP-TOP CLOSURE
SPECIAL FEATURES: PH RANGE OF 5.0 TO 7.0;WHITE,SMOOTH LOTIO IN A BASE CONSISTING OF PURIFIED WATER,TRIETHANOLAMINE,DOCUSATE SODIUM,PROPYLENE GLYCOL,GLYCERYL STEARATE,PEG 40 STEARATE,PEG 4 DILAURATE,POLYOXYETHYLENE LAURYL ETHER,METHYLPARABEN,AND CARBOXYVINYL
~1: COPOLYMER;ADMINISTRATION:TOPICAL
Related Searches:
NDC19810-0533-50
MINERAL OIL LOTION,LANOLATED
NSN, MFG P/N
6505010092897
NSN
6505-01-009-2897
NDC19810-0533-50
MINERAL OIL LOTION,LANOLATED
NSN, MFG P/N
6505010092897
NSN
6505-01-009-2897
MFG
BRISTOL-MYERS SQUIBB CO P O BOX 5250 PRINCETON NJ 08543-5250
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MINERAL OIL LOTION LANOLATED 6.5 OZ BT
PRIMARY CONTAINER CONTENT QUANTITY: 6.500 OUNCES
PRIMARY CONTAINER TYPE: BOTTLE WITH FLIP-TOP CLOSURE
SPECIAL FEATURES: PH RANGE OF 5.0 TO 7.0;WHITE,SMOOTH LOTIO IN A BASE CONSISTING OF PURIFIED WATER,TRIETHANOLAMINE,DOCUSATE SODIUM,PROPYLENE GLYCOL,GLYCERYL STEARATE,PEG 40 STEARATE,PEG 4 DILAURATE,POLYOXYETHYLENE LAURYL ETHER,METHYLPARABEN,AND CARBOXYVINYL
~1: COPOLYMER;ADMINISTRATION:TOPICAL
Related Searches:
NDC00409-3024-01
SODIUM NITROPRUSSIDE,USP
NSN, MFG P/N
6505010095019
NSN
6505-01-009-5019
NDC00409-3024-01
SODIUM NITROPRUSSIDE,USP
NSN, MFG P/N
6505010095019
NSN
6505-01-009-5019
MFG
AMERISOURCEBERGEN DRUG CORPORATION DIV CORPORATE OFFICE
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SODIUM NITROPRUSSIDE STERILE USP 50MG
III SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLIGRAMS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: NOT FOR DIRECT INJECTION
Related Searches:
NDC00003-0113-50
CEPHRADINE CAPSULES,USP
NSN, MFG P/N
6505010099531
NSN
6505-01-009-9531
NDC00003-0113-50
CEPHRADINE CAPSULES,USP
NSN, MFG P/N
6505010099531
NSN
6505-01-009-9531
MFG
CARDINAL HEALTH 200 LLC
Description
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 144
(NON-CORE DATA) INTERMEDIATE PACKAGE QUANTITY: 12
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.029 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.38 POUNDS
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS CEPHRADINE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEPHRADINE CAPSULES USP 250MG 100S
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
ALUPENT
METAPROTERENOL SULFATE TABLETS,USP
NSN, MFG P/N
6505010103044
NSN
6505-01-010-3044
ALUPENT
METAPROTERENOL SULFATE TABLETS,USP
NSN, MFG P/N
6505010103044
NSN
6505-01-010-3044
MFG
BOEHRINGER INGELHEIM PHARMACEUTICALS INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIGRAMS METAPROTERENOL SULFATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: METAPROTERENOL SULFATE TABLETS 20MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
ALUPENT TABLETS
METAPROTERENOL SULFATE TABLETS,USP
NSN, MFG P/N
6505010103044
NSN
6505-01-010-3044
ALUPENT TABLETS
METAPROTERENOL SULFATE TABLETS,USP
NSN, MFG P/N
6505010103044
NSN
6505-01-010-3044
MFG
BOEHRINGER INGELHEIM PHARMACEUTICALS INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIGRAMS METAPROTERENOL SULFATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: METAPROTERENOL SULFATE TABLETS 20MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00043-0063-51
METAPROTERENOL SULFATE TABLETS,USP
NSN, MFG P/N
6505010103044
NSN
6505-01-010-3044
NDC00043-0063-51
METAPROTERENOL SULFATE TABLETS,USP
NSN, MFG P/N
6505010103044
NSN
6505-01-010-3044
MFG
NOVARTIS PHARMACEUTICALS CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIGRAMS METAPROTERENOL SULFATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: METAPROTERENOL SULFATE TABLETS 20MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00182-1284-01
METAPROTERENOL SULFATE TABLETS,USP
NSN, MFG P/N
6505010103044
NSN
6505-01-010-3044
NDC00182-1284-01
METAPROTERENOL SULFATE TABLETS,USP
NSN, MFG P/N
6505010103044
NSN
6505-01-010-3044
MFG
GOLDLINE LABORATORIES INC. DBA GOLDLINE LABORATORIES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIGRAMS METAPROTERENOL SULFATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: METAPROTERENOL SULFATE TABLETS 20MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00332-2232-09
METAPROTERENOL SULFATE TABLETS,USP
NSN, MFG P/N
6505010103044
NSN
6505-01-010-3044
NDC00332-2232-09
METAPROTERENOL SULFATE TABLETS,USP
NSN, MFG P/N
6505010103044
NSN
6505-01-010-3044
MFG
BIOCRAFT LABORATORIES INC CORPORATE HQ
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIGRAMS METAPROTERENOL SULFATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: METAPROTERENOL SULFATE TABLETS 20MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00597-0072-01
METAPROTERENOL SULFATE TABLETS,USP
NSN, MFG P/N
6505010103044
NSN
6505-01-010-3044
NDC00597-0072-01
METAPROTERENOL SULFATE TABLETS,USP
NSN, MFG P/N
6505010103044
NSN
6505-01-010-3044
MFG
BOEHRINGER INGELHEIM PHARMACEUTICALS INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIGRAMS METAPROTERENOL SULFATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: METAPROTERENOL SULFATE TABLETS 20MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC49884-0259-01
METAPROTERENOL SULFATE TABLETS,USP
NSN, MFG P/N
6505010103044
NSN
6505-01-010-3044
NDC49884-0259-01
METAPROTERENOL SULFATE TABLETS,USP
NSN, MFG P/N
6505010103044
NSN
6505-01-010-3044
MFG
PAR PHARMACEUTICAL INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIGRAMS METAPROTERENOL SULFATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: METAPROTERENOL SULFATE TABLETS 20MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00052-0460-02
PYRIDOSTIGMINE BROMIDE INJECTION,USP
NSN, MFG P/N
6505010103050
NSN
6505-01-010-3050
NDC00052-0460-02
PYRIDOSTIGMINE BROMIDE INJECTION,USP
NSN, MFG P/N
6505010103050
NSN
6505-01-010-3050
MFG
ORGANON USA INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS PYRIDOSTIGMINE BROMIDE PER MILLILITER
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 MILLILITERS
PRIMARY CONTAINER TYPE: AMPUL
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
REGONOL INJECTION
PYRIDOSTIGMINE BROMIDE INJECTION,USP
NSN, MFG P/N
6505010103050
NSN
6505-01-010-3050
REGONOL INJECTION
PYRIDOSTIGMINE BROMIDE INJECTION,USP
NSN, MFG P/N
6505010103050
NSN
6505-01-010-3050
MFG
ORGANON USA INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS PYRIDOSTIGMINE BROMIDE PER MILLILITER
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 MILLILITERS
PRIMARY CONTAINER TYPE: AMPUL
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
019-5374-92
METHYCLOTHIAZIDE AN
NSN, MFG P/N
6505010103065
NSN
6505-01-010-3065
MFG
MALLINCKRODT INC ANESTHESIA PRODUCTS
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: 2.5 MG METHYCLOTHIAZIDE,0.1 MG RESERPINE,SCORED,100 TABLETS PER BOTTLE
Related Searches:
DIVTENSEN-R
METHYCLOTHIAZIDE AN
NSN, MFG P/N
6505010103065
NSN
6505-01-010-3065
MFG
MALLINCKRODT INC ANESTHESIA PRODUCTS
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: 2.5 MG METHYCLOTHIAZIDE,0.1 MG RESERPINE,SCORED,100 TABLETS PER BOTTLE
Related Searches:
781
TOBRAMYCIN INJECTION,USP
NSN, MFG P/N
6505010103066
NSN
6505-01-010-3066
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 40.000 MILLIGRAMS TOBRAMYCIN EQUIVALENT OF BASE PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: TOBRAMYCIN INJECTION USP 40MG/ML 2ML BT
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
Related Searches:
NDC00002-1499-01
TOBRAMYCIN INJECTION,USP
NSN, MFG P/N
6505010103066
NSN
6505-01-010-3066
NDC00002-1499-01
TOBRAMYCIN INJECTION,USP
NSN, MFG P/N
6505010103066
NSN
6505-01-010-3066
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 40.000 MILLIGRAMS TOBRAMYCIN EQUIVALENT OF BASE PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: TOBRAMYCIN INJECTION USP 40MG/ML 2ML BT
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
